قاعدة المعارف الطبية

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

European Association of Neuro-Oncologyعلم الأورام2020النشر الرسمي

الملخص الوثائقي لـ ASEM

Official European Association of Neuro-Oncology document (2020) on “Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up”. Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are common and often dose-limiting side effects. In patients with chemotherapy-induced peripheral neurotoxicity (CIPN), recovery is in general partial with residual deficits in most patients. In these Clinical Practice Guidelines, recommendations on diagnosis, prevention and treatment of peripheral neurotoxicity and specific aspe.

يساعد هذا الملخص على التعرّف على الوثيقة. بالنسبة إلى التوصيات السريرية، يُرجى دائمًا الرجوع إلى النسخة الرسمية وتاريخ آخر تحديث لها.

وثيقة رسمية